Literature DB >> 20556673

Bone densitometry and vertebral fracture assessment.

E Michael Lewiecki1.   

Abstract

Measurement of bone mineral density (BMD) is used to diagnose osteoporosis, assess fracture risk, and monitor response to therapy. Of the different methods for measuring BMD, dual-energy X-ray absorptiometry (DXA) is the only technology for classifying BMD according to criteria established by the World Health Organization (WHO) and the only technology that is validated for BMD input with the WHO fracture risk assessment algorithm, FRAX. Vertebral fracture assessment (VFA) by DXA provides an image of the thoracic and lumbar spine for the purpose of detecting vertebral fracture deformities. Identification of a previously unrecognized vertebral fracture may change diagnostic classification, assessment of fracture risk, and treatment decisions. In comparison with standard radiographs of the spine, the correlation for detecting moderate and severe vertebral fractures is good, with a smaller dose of ionizing irradiation, greater patient convenience, and lower cost. Optimal performance of DXA and VFA requires training and adherence to quality standards.

Entities:  

Mesh:

Year:  2010        PMID: 20556673     DOI: 10.1007/s11914-010-0018-z

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  45 in total

1.  Monitoring osteoporosis therapy with bone densitometry: a vital tool or regression toward mediocrity?

Authors:  S L Bonnick
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

Review 2.  Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology.

Authors:  Ann Cranney; Peter Tugwell; George Wells; Gordon Guyatt
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

3.  Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography.

Authors:  R Paul Crawford; Christopher E Cann; Tony M Keaveny
Journal:  Bone       Date:  2003-10       Impact factor: 4.398

4.  Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.

Authors:  Mary L Bouxsein; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

5.  Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice.

Authors:  John T Schousboe; C Rowan Debold
Journal:  Osteoporos Int       Date:  2005-09-20       Impact factor: 4.507

6.  Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.

Authors:  Marc C Hochberg; Susan Greenspan; Richard D Wasnich; Paul Miller; Desmond E Thompson; Philip D Ross
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

8.  Visual identification of vertebral fractures in osteoporosis using morphometric X-ray absorptiometry.

Authors:  L Ferrar; G Jiang; R Eastell; N F A Peel
Journal:  J Bone Miner Res       Date:  2003-05       Impact factor: 6.741

9.  The incidence of vertebral fractures in men and women: the Rotterdam Study.

Authors:  Marjolein Van der Klift; Chris E D H De Laet; Eugene V McCloskey; Albert Hofman; Huibert A P Pols
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

10.  Assessing response to osteoporosis therapy.

Authors:  E M Lewiecki; N B Watts
Journal:  Osteoporos Int       Date:  2008-06-11       Impact factor: 4.507

View more
  26 in total

Review 1.  Relationship Between Bariatric Surgery and Bone Mineral Density: a Meta-analysis.

Authors:  Byung-Joon Ko; Seung Kwon Myung; Kyung-Hwan Cho; Yong Gyu Park; Sin Gon Kim; Do Hoon Kim; Seon Mee Kim
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

Review 2.  Examining the link between bariatric surgery, bone loss, and osteoporosis: a review of bone density studies.

Authors:  Lesley M Scibora; Sayeed Ikramuddin; Henry Buchwald; Moira A Petit
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

3.  The ratio of anterior and posterior vertebral heights reinforces the utility of DXA in assessment of vertebrae strength.

Authors:  Grzegorz Tatoń; Eugeniusz Rokita; Mariusz Korkosz; Andrzej Wróbel
Journal:  Calcif Tissue Int       Date:  2014-05-23       Impact factor: 4.333

4.  Alterations of bone microstructure and strength in end-stage renal failure.

Authors:  A Trombetti; C Stoermann; T Chevalley; B Van Rietbergen; F R Herrmann; P-Y Martin; R Rizzoli
Journal:  Osteoporos Int       Date:  2012-10-26       Impact factor: 4.507

5.  Effect of gate choice on backscatter difference measurements of cancellous bone.

Authors:  Brent K Hoffmeister; Ann M Viano; Luke C Fairbanks; Sheldon C Ebron; Joseph A McPherson; Matthew T Huber
Journal:  J Acoust Soc Am       Date:  2017-08       Impact factor: 1.840

6.  Unscheduled Radiologic Examination Orders in the Electronic Health Record: A Novel Resource for Targeting Ambulatory Diagnostic Errors in Radiology.

Authors:  Ronilda Lacson; Michael J Healey; Laila R Cochon; Romeo Laroya; Keith D Hentel; Adam B Landman; Sunil Eappen; Giles W Boland; Ramin Khorasani
Journal:  J Am Coll Radiol       Date:  2020-01-16       Impact factor: 5.532

Review 7.  Advances in bone imaging for osteoporosis.

Authors:  Judith E Adams
Journal:  Nat Rev Endocrinol       Date:  2013-01       Impact factor: 43.330

8.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2018-10-15       Impact factor: 4.507

Review 9.  Optimising the management of osteoporosis.

Authors:  Ziad Farrah; Ali Sm Jawad
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

Review 10.  Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practice.

Authors:  Michael Maricic
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.